These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3605066)

  • 1. Phosphoglycerate kinase San Francisco: a new variant associated with hemolytic anemia but not with neuromuscular manifestations.
    Guis MS; Karadsheh N; Mentzer WC
    Am J Hematol; 1987 Jun; 25(2):175-82. PubMed ID: 3605066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human erythrocyte phosphoglycerate kinase deficiency: presence in a deficient patient of a stable variant with lowered catalytic activity.
    Kahn A; Cottreau D; Galand C; Boivin P
    Clin Chim Acta; 1976 May; 69(1):21-8. PubMed ID: 817852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary deficiency of phosphoglycerate kinase: a new variant in erythrocytes and leucocytes, not associated with haemolytic anaemia.
    Krietsch WK; Krietsch H; Kaiser W; Dünnwald M; Kuntz GW; Duhm J; Bücher T
    Eur J Clin Invest; 1977 Oct; 7(5):427-35. PubMed ID: 411673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of normal and variant human phosphoglycerate kinase.
    Huang IY; Fujii H; Yoshida A
    Hemoglobin; 1980; 4(5-6):601-9. PubMed ID: 7440217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cultured lymphoblastoid cells for the study of abnormal enzymes: molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemia.
    Fujii H; Chen SH; Akatsuka J; Miwa S; Yoshida A
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2587-90. PubMed ID: 6941312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new case of phosphoglycerate kinase deficiency: PGK Creteil associated with rhabdomyolysis and lacking hemolytic anemia.
    Rosa R; George C; Fardeau M; Calvin MC; Rapin M; Rosa J
    Blood; 1982 Jul; 60(1):84-91. PubMed ID: 7082849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy.
    Tamai M; Kawano T; Saito R; Sakurai K; Saito Y; Yamada H; Ida H; Akiyama M
    Int J Hematol; 2014 Oct; 100(4):393-7. PubMed ID: 24934115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation.
    Ramírez-Bajo MJ; Repiso A; la Ossa PP; Bañón-Maneus E; de Atauri P; Climent F; Corrons JL; Cascante M; Carreras J
    Blood Cells Mol Dis; 2011 Mar; 46(3):206-11. PubMed ID: 21269848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a phosphoglycerate kinase variant associated with hemolytic anemia.
    Yoshida A; Miwa S
    Am J Hum Genet; 1974 May; 26(3):378-84. PubMed ID: 4827366
    [No Abstract]   [Full Text] [Related]  

  • 10. Normal mRNA content in a phosphoglycerate kinase variant with severe enzyme deficiency.
    Tani K; Takizawa T; Yoshida A
    Am J Hum Genet; 1985 Sep; 37(5):931-7. PubMed ID: 3840329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phosphoglycerate kinase variant, PGK Uppsala, associated with hemolytic anemia.
    Hjelm M; Wadam B; Yoshida A
    J Lab Clin Med; 1980 Dec; 96(6):1015-21. PubMed ID: 7430759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization.
    Fermo E; Bianchi P; Chiarelli LR; Maggi M; Mandarà GM; Vercellati C; Marcello AP; Barcellini W; Cortelezzi A; Valentini G; Zanella A
    Mol Genet Metab; 2012 Aug; 106(4):455-61. PubMed ID: 22705348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular abnormality of a phosphoglycerate kinase variant (PGK-Alabama).
    Yoshida A; Twele TW; Davé V; Beutler E
    Blood Cells Mol Dis; 1995; 21(3):179-81. PubMed ID: 8673469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a phosphoglycerate kinase deficiency variants not associated with hemolytic anemia.
    Krietsch WK; Eber SW; Haas B; Ruppelt W; Kuntz GW
    Am J Hum Genet; 1980 May; 32(3):364-73. PubMed ID: 6770677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phosphoglycerate kinase mutant (PGK Herlev; D285V) in a Danish patient with isolated chronic hemolytic anemia: mechanism of mutation and structure-function relationships.
    Valentin C; Birgens H; Craescu CT; Brødum-Nielsen K; Cohen-Solal M
    Hum Mutat; 1998; 12(4):280-7. PubMed ID: 9744480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoglycerate kinase abnormalities: functional, structural and genomic aspects.
    Yoshida A; Tani K
    Biomed Biochim Acta; 1983; 42(11-12):S263-7. PubMed ID: 6689547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of a novel variant of phosphoglycerate kinase 1 deficiency
    Gutierrez E; Bayes MG; Mallick J; Dell'osso L; Lyapichev KA; Muthukumar A
    Pediatr Hematol Oncol; 2023 Feb; 40(1):76-85. PubMed ID: 35608390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation.
    Hamano T; Mutoh T; Sugie H; Koga H; Kuriyama M
    Neurology; 2000 Mar; 54(5):1188-90. PubMed ID: 10720297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of increased 2,3-diphosphoglycerate on flux through the oxidative pathway in phosphoglycerate kinase deficiency.
    Svirklys LG; O'Sullivan WJ
    Clin Chim Acta; 1985 Jun; 148(3):167-71. PubMed ID: 4042351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoglycerate kinase deficiency myopathy: biochemical and immunological studies of the mutant enzyme.
    Bresolin N; Miranda A; Chang HW; Shanske S; DiMauro S
    Muscle Nerve; 1984 Sep; 7(7):542-51. PubMed ID: 6544372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.